Fed. Circ. Will Hear Mylan Hatch-Waxman Jurisdiction Case

The Federal Circuit agreed Tuesday to hear arguments over a judge's decision that Mylan Pharmaceuticals Inc. is subject to jurisdiction in Delaware in a suit over generic versions of AstraZeneca AB...

Already a subscriber? Click here to view full article